Rifamycin SV

Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.

Cross Reference

Introduction

To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Rifamycin SV?

Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Rifamycin SV

MeSH term MeSH ID Detail
Diarrhea D003967 32 associated lipids
Pain D010146 64 associated lipids
Abscess D000038 13 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Osteomyelitis D010019 10 associated lipids
Alzheimer Disease D000544 76 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Anaphylaxis D000707 35 associated lipids
Per page 10 20 | Total 18

PubChem Associated disorders and diseases

What pathways are associated with Rifamycin SV

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Rifamycin SV?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Rifamycin SV?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

What genes are associated with Rifamycin SV?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Rifamycin SV

Download all related citations
Per page 10 20 50 100 | Total 175
Authors Title Published Journal PubMed Link
Qi F et al. Deciphering the late steps of rifamycin biosynthesis. 2018 Nat Commun pmid:29904078
Zhang Y et al. GlnR positive transcriptional regulation of the phosphate-specific transport system pstSCAB in Amycolatopsis mediterranei U32. 2018 Acta Biochim. Biophys. Sin. (Shanghai) pmid:30007316
Testa A et al. Preclinical Evaluation of [F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters. 2018 Contrast Media Mol Imaging pmid:30154685
Lin SW et al. Rifamycin SV MMX for the treatment of traveler's diarrhea. 2017 Expert Opin Pharmacother pmid:28697313
Narang SS et al. Molecular insights into the inhibitory mechanism of rifamycin SV against β-microglobulin aggregation: A molecular dynamics simulation study. 2017 Int. J. Biol. Macromol. pmid:28455257
Bi YA et al. Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes. 2017 AAPS J pmid:28188574
Alsdurf H et al. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. 2016 Lancet Infect Dis pmid:27522233
Sayyed K et al. Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate. 2016 Toxicology pmid:27450509
Li Q et al. [Ocular syndromes in patients with neurobrucellosis]. 2015 Zhonghua Yan Ke Za Zhi pmid:26888270
Li W et al. Development of a sensitive and rapid method for rifampicin impurity analysis using supercritical fluid chromatography. 2015 J Pharm Biomed Anal pmid:26103526
Nagavalli M et al. Enhanced rifamycin SV production by submerged fermentation using Amycolatopsis mediterranei. 2015 Appl. Microbiol. Biotechnol. pmid:26026938
Pyta K et al. Regioselective long-range proton transfer in new rifamycin antibiotics: a process in which crown ethers act as stronger Brønsted bases than amines. 2015 Chemphyschem pmid:25639734
Torbeev V et al. Substitution of proline32 by α-methylproline preorganizes β2-microglobulin for oligomerization but not for aggregation into amyloids. 2015 J. Am. Chem. Soc. pmid:25633201
Nagavalli M et al. Solid state fermentation and production of rifamycin SV using Amycolatopsis mediterranei. 2015 Lett. Appl. Microbiol. pmid:25256628
Gurel MS et al. Comparison of the effects of topical fusidic acid and rifamycin on wound healing in rats. 2015 Int Wound J pmid:23489386
Shao ZH et al. A preliminary study of the mechanism of nitrate-stimulated remarkable increase of rifamycin production in Amycolatopsis mediterranei U32 by RNA-seq. 2015 Microb. Cell Fact. pmid:26041361
Aygün F et al. The protective effect of topical rifamycin treatment against sternal wound infection in diabetic patients undergoing on-pump coronary artery bypass graft surgery. 2014 May-Jun Cardiovasc J Afr pmid:24687038
Przybylski P et al. 13C and 15N CP/MAS, 1H-15N SCT CP/MAS and FTIR spectroscopy as tools for qualitative detection of the presence of zwitterionic and non-ionic forms of ansa-macrolide 3-formylrifamycin SV and its derivatives in solid state. 2014 Jan-Feb Magn Reson Chem pmid:24347399
Sha W [How to use rifamycin rationally: the key issue to prevent multidrug-resistant tuberculosis]. 2014 Zhonghua Jie He He Hu Xi Za Zhi pmid:25537407
Chiou WJ et al. In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia. 2014 Xenobiotica pmid:23886114
Kawde AN et al. Adsorptive stripping voltammetry of antibiotics rifamycin SV and rifampicin at renewable pencil electrodes. 2014 Acta Chim Slov pmid:25125124
Evans SE et al. The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain. 2014 PLoS ONE pmid:24595451
Dechert-Schmitt AM et al. Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations: reinventing the chemistry of carbonyl addition. 2014 Nat Prod Rep pmid:24514754
Kumar S et al. Synthesis and biological evaluation of trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxyalkylamine derivatives against drug susceptible, non-replicating M. tuberculosis H37Rv and clinical multidrug resistant strains. 2013 Bioorg. Med. Chem. Lett. pmid:23474387
Singh R et al. No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients. 2013 AIDS pmid:23014518
Rosette C et al. Anti-inflammatory and immunomodulatory activities of rifamycin SV. 2013 Int. J. Antimicrob. Agents pmid:23756321
Falkinham JO et al. Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria. 2012 Tuberculosis (Edinb) pmid:22209468
Calatayud M et al. In vitro study of transporters involved in intestinal absorption of inorganic arsenic. 2012 Chem. Res. Toxicol. pmid:22214486
Farrell DJ et al. In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficile. 2011 Antimicrob. Agents Chemother. pmid:21149623
Borsali E et al. [Ornithinimicrobium pekingense ocular infection]. 2011 Med Mal Infect pmid:21440391
Shao Z et al. Identification and functional analysis of a nitrate assimilation operon nasACKBDEF from Amycolatopsis mediterranei U32. 2011 Arch. Microbiol. pmid:21424691
Di Stefano AF et al. Systemic absorption of rifamycin SV MMX administered as modified-release tablets in healthy volunteers. 2011 Antimicrob. Agents Chemother. pmid:21402860
Woods LA et al. Ligand binding to distinct states diverts aggregation of an amyloid-forming protein. 2011 Nat. Chem. Biol. pmid:21873994
Yuan H et al. Two genes, rif15 and rif16, of the rifamycin biosynthetic gene cluster in Amycolatopsis mediterranei likely encode a transketolase and a P450 monooxygenase, respectively, both essential for the conversion of rifamycin SV into B. 2011 Acta Biochim. Biophys. Sin. (Shanghai) pmid:21986914
Zhao J et al. Preparation and application of rifamycin-capped (3-(2-O-β-cyclodextrin)-2-hydroxypropoxy)-propylsilyl-appended silica particles as chiral stationary phase for high-performance liquid chromatography. 2010 Talanta pmid:21035677
Vigliaroli E et al. Double pathological fracture of mandibula caused by actinomycotic osteomyelitis: a case report. 2010 Minerva Stomatol pmid:20940689
Velichka D et al. Experimental and clinical studies on Rifacinna--the new effective antituberculous drug (review). 2010 Recent Pat Antiinfect Drug Discov pmid:19929844
Sharma P et al. Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions. 2010 Xenobiotica pmid:19919292
Swift B et al. Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytes. 2010 Pharm. Res. pmid:20652625
Mariner KR et al. Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymerase. 2010 Antimicrob. Agents Chemother. pmid:20660693
Kockar F et al. Differential effects of some antibiotics on paraoxonase enzyme activity on human hepatoma cells (HepG2) in vitro. 2010 J Enzyme Inhib Med Chem pmid:20429781
Zhao W et al. Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism. 2010 Cell Res. pmid:20567260
Sarr FS et al. A novel biochromatographic Oatp2 column to study the transmembrane transport of statins. 2010 J Pharm Biomed Anal pmid:20045601
Magdalan J et al. Comparative antidotal efficacy of benzylpenicillin, ceftazidime and rifamycin in cultured human hepatocytes intoxicated with α-amanitin. 2009 Arch. Toxicol. pmid:19730819
Antonicelli L et al. IgE-mediated reactions to rifaximin and rifamycin SV and cross-reactivity among rifamycins. 2009 Allergy pmid:19416136
Garver E et al. Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat. 2008 Drug Metab. Dispos. pmid:18755851
Williams PG et al. Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola. 2007 J. Nat. Prod. pmid:17253854
Necula M et al. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. 2007 J. Biol. Chem. pmid:17284452
Yu H et al. A complex role of Amycolatopsis mediterranei GlnR in nitrogen metabolism and related antibiotics production. 2007 Arch. Microbiol. pmid:17364194
Hartkoorn RC et al. A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin. 2007 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:17643357